Magnesium EQL Pharma
The drug Magnesium EQL Pharma has today been approved for sale by the Swedish Medicines Agency.Magnesium EQL Pharma is used in diagnosed or suspected magnesium deficiency as well as prophylaxis in idiopathic recurrent renal disease. The drug Magnesium EQL Pharma is a pronounced niche generic where EQL Pharma becomes the only, and first, generic on the Swedish market for more than 35 years. The product is medium sized with approximately 8 MSEK in total annual sales in the Swedish market. The product is expected to be launched around the year 2018/2019.